Skip to main content
. 2023 Feb 5;14(3):434–445. doi: 10.7150/jca.81588

Table 3.

Intraoperative and postoperative outcomes of the two groups after PSM

Variables NAC (N=413) Surgery (N=413) P value
Operation, N% 0.843
Radical resection 408 410
Palliative resection 1(0.26) 1(0.26)
Explora 4(1.02) 2(0.52)
Surgical approach N% 0.0000*
Missing 2 10
Open 96(23.36) 237(58.81)
MIE 315(76.64) 163(40.45)
Hybrid operation 0(0.00) 3(0.74)
Open approach, N% 0.2145
Missing 96 237
Left Thoracic Approach 41(42.71) 119(50.21)
Right Thoracic Approach 55(57.29) 118(49.79)
Anastomotic methods, N% 0.3390
Missing 0 4
Intrathoracic anastomosis 3(0.73) 6(1.47)
Cervical anastomosis 410(99.27) 403(98.53)
Operative time (min) <0.0001*
Mean (standard deviation) 283.2(79.46) 259.2(80.99)
Median (Q1,Q3) 270.0(240.0, 330.0) 245.0(200.0, 310.0)
Second operation, N% 1.0000
Yes 1(0.24) 1(0.24)
No 412(99.76) 412(99.76)
Blood loss (ml) 0.1371
Missing 90(323) 152(261)
Mean (standard deviation) 179.0(118.72) 197.7(120.22)
Median (Q1,Q3) 150.0(100.0, 200.0) 200.0(100.0, 200.0)
Postoperative hospital stay <0.0001*
Mean (standard deviation) 16.1(11.96) 17.4(9.91)
Median (Q1,Q3) 13.0(9.0, 18.0) 14.0(13.0, 18.0)
Maximum, Minimum 1, 113 4, 75
Fasting days 0.2060
Mean (standard deviation) 8.8(13.03) 9.1(8.29)
Median (Q1,Q3) 7.0(1.5, 9.5) 8.0(3.0, 11.0)
Maximum, Minimum 1, 84 1, 42
Chest tube drainage days 0.2687
Mean (standard deviation) 6.4(3.89) 7.4(3.66)
Median (Q1,Q3) 6.0(3.5, 9.0) 7.0(5.5, 9.0)
Maximum, Minimum 1, 13 1, 27
Mediastinal tube drainage days 0.8690
Mean (standard deviation) 11.6(11.03) 8.7(4.30)
Median (Q1,Q3) 8.0(6.0, 12.0) 6.0(6.0, 13.0)
Maximum, Minimum 4, 42 3, 15
Lymph nodes retrieved 0.0295*
Mean (standard deviation) 22.1(13.59) 22.8(10.97)
Median (Q1,Q3) 19.0(12.0, 30.0) 22.0(15.0, 29.0)
Positive lymph nodes 0.5008
Mean (standard deviation) 1.0(2.04) 1.3(2.45)
Median (Q1,Q3) 0.0(0.0, 1.0) 0.0(0.0, 2.0)
Maximum, Minimum 0, 19 0, 18
Complications, n(%) 171(41.40) 173(41.89) 0.8877
Complications 0.5546
Mean (standard deviation) 0.8(1.30) 0.9(1.54)
Median (Q1,Q3) 0.0(0.0, 1.0) 0.0(0.0, 1.0)
Maximum, Minimum 0, 7 0, 9
Number of complications per patients N (%) 0.4320
0 242(58.60) 240(58.11)
1 87(21.07) 74(17.92)
2 39(9.44) 41(9.93)
≥3 45(10.90) 58(14.04)
Clavien‒Dindo grading system, N (%) 0.7082
Missing 147(266) 155(258)
I 60(40.82) 65(41.94)
II 76(51.70) 82(52.90)
IV-a 11(7.48) 8(5.16)
Pneumonia, N (%) 93(22.52) 101(24.46) 0.5114
Respiratory failure, N (%) 1(0.24) 3(0.73) 0.6241
Mediastinal infection, N (%) 0(0.00) 1(0.24) 1.0000
Pneumoderm, N (%) 2(0.48) 5(1.21) 0.4511
Myocardial infarction, N (%) 0(0.00) 1(0.24) 1.0000
Arrhythmia, N (%) 17(4.12) 23(5.57) 0.3308
Urinary infection, N (%) 0(0.00) 1(0.24) 1.0000
Incision infection, N (%) 0(0.00) 4(0.97) 0.1241
Chylothorax, N (%) 2(0.48) 0(0.00) 0.4994
Recurrent laryngeal nerve injury, N (%) 45(10.90) 60(14.53) 0.117
Anastomotic leakage, N (%) 15(3.63) 17(4.12) 0.7184
Thoracic gastric fistula, N (%) 1(0.24) 0(0.00) 1.0000
Tracheopleural fistula, N (%) 0(0.00) 1(0.24) 1.0000
Bronchopleural fistula, N (%) 0(0.00) 1(0.24) 1.0000
Local recurrence, N% 0.2216
Yes 40(9.69) 51(12.35)
No 373(90.31) 362(87.65)
Distant metastasis, N% 0.2078
Yes 37(8.96) 48(11.62)
No 376(91.04) 365(88.38)

NAC, neoadjuvant chemotherapy; N, number; MIE, minimally invasive oesophagectomy; * Statistically significant (p<0.05).